Evidence map›Paper›PMID 41842337›Full record

ArticleMicrobiology spectrum2026

Repurposing flufenamic acid as a putative PmrB-directed adjuvant to restore colistin activity in

Chuleeporn Phanus-Umporn, Nuttapat Anuwongcharoen, Chawalit Chatupheeraphat, Noramon Kaewsai, Warawan Eiamphungporn

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chuleeporn Phanus-UmpornDepartment of Community Medical Technology, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, Thailand.ORCID 0000-0001-5439-8462
Nuttapat AnuwongcharoenDepartment of Community Medical Technology, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, Thailand.ORCID 0000-0001-5361-5314
Chawalit ChatupheeraphatCenter for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, Thailand.ORCID 0000-0003-4166-3591
Noramon KaewsaiCenter for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, Thailand.
Warawan EiamphungpornDepartment of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.ORCID 0000-0003-4698-3236

Funding

National Research Council of Thailand (NRCT) and Mahidol University N42A650351
6 · The paper itself

Abstract

Antimicrobial resistance in gram-negative bacteria has renewed reliance on colistin, yet resistance to this last-line agent is increasing. In

Indexed as

Anti-Bacterial AgentsBacterial ProteinsColistinDrug RepositioningFlufenamic AcidKlebsiella pneumoniaeTranscription FactorsDrug Resistance, BacterialKlebsiella InfectionsMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial ProteinsColistinFlufenamic AcidPmrB protein, bacteriaTranscription Factorsantibiotic adjuvantcolistin resistanceflufenamic acidKlebsiella pneumoniaePmrBvirtual screening

Identifiers

PMID41842337
PMCPMC13055304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.